Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Underperformer
2390.0000 11.20 (0.47%)
NSE Jun 12, 2025 15:31 PM
Volume: 449.4K
 

2390.00
0.47%
Asit C Mehta Investment Interrmediates
Mankind benefits from the industry experience and business acumen of their individual Promoters and is driven by the 3 core values of quality, affordability and accessibility. Their professional and experienced management team has been critical in building their brands, growing their operations, and maintaining capital efficiency despite their emphasis on affordable product offerings.
Number of FII/FPI investors increased from 624 to 640 in Mar 2025 qtr.
More from Mankind Pharma Ltd.
Recommended